cagrilintide semaglutide combination trial results Novo Nordisk: Can CagriSema Show 25% Weight Loss In REDEFINE-1 Trial? A new drug combo of

A new drug combo of semaglutide (GLP 1 receptor agonist) with cagrilintide (amylin analogue) failed to do as well as tirzepatide (GLP 1 GIP receptor agonist). The future of these medicines is hitting different receptors. We are all anxiously awaiting more research on the combination of cagrilintide and semaglutide (#ozempic #wegovy) which has been shown in global studies to induce very meaningful #weightloss. This study assessed the efficacy Trial Scorecard: REDEFINE 1 and 2 Weight Loss Efficacy of Cagrilintide and Semaglutide gutsandgrowth

SKU: 98714860426 · From equiscorp.hu